Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L) LSE
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.24B |
| Enterprise Value | 3.29B |
| P/E Ratio | 17.52 |
| PEG Ratio | 2.1 |
| Price/Sales Ratio | 4.35 |
| Price/Book Ratio | 4.62 |
| Enterprise/Revenue | 4.38 |
| Enterprise/EBITDA | 13.12 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.25 |
| Operating Margin | 0.22 |
AD
Management Effectiveness
| Return On Assets | 0.18 |
| Return On Equity | 0.29 |
Income Statement
| Revenue | 743.48M |
| Revenue/Share | 16.2 |
| Gross Profit | 451.65M |
| EBITDA | 203.52M |
| Net Income | 140.44M |
| Diluted EPS | 2.75 |
Balance Sheet
| Total Cash | 128.07M |
| Total Cash/Share | 1.39 |
| Total Debt | 107.69M |
| Total Debt/Equity | 0.13 |
| Current Ratio | 2.68 |
| Book Value Per Share | 15.61 |
Price History
| 52-Week Change | 18.96 |
| 52-Week High | 87.5 |
| 52-Week Low | 52.45 |
| Moving Average 50 Days | 60.01 |
| Moving Average 200 Days | 65.88 |
Statistics
| Average Volume | 9,049 |
| Shares Outstanding | 51.14M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.96 |
| Trailing Annual Dividend Yield | 1.36 |
| Payout Ratio | 0.24 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
